Continuing Education
Diabetes
Managing Type 2 Diabetes and Promoting Metabolic & Cardiovascular Health
This program is sponsored by the Nurse Practitioner Healthcare Foundation in collaboration with the Illinois Critical Hospital Network, University of Illinois, Rockford, and the Michigan Academy of Family Physicians.
It is funded by an unrestricted educational grant from Takeda Pharmaceuticals North America, Inc.
About Managing Type 2 Diabetes and Promoting Metabolic & Cardiovascular Health:
The epidemic rise in the prevalence of diabetes during the previous 25 years has produced a ripple
effect in terms of disease and economic burdens. Microvascular and macrovascular complications of
diabetes are underestimated. Early diagnosis, aggressive treatment of glucose, weight reduction,
weight control all assist in decreasing the morbidity and mortality of this disease.
Accreditation Statement: This continuing nursing education activity (CEARP #8948, 10/31/09) is approved by the Washington State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Approved for 1.5 contact hours.
Statement of Need: The front line for diagnosis, management, and prevention of complications for diabetes is the primary healthcare professional. It is a struggle to assist patients with the battle to manage lifestyle changes, control glucose, and prevent complications. Continuing education is one avenue to keep the primary healthcare professionals up-to-date and motivated.
Intended Audience: This program has been developed for nurse practitioners, physician assistants, nurses, and primary care physicians.
Educational Objectives:
At the conclusion of this activity, the participant should be able to:
- Identify criteria for diagnosing type 2 diabetes
- Describe lifestyle interventions designed to manage insulin resistance
- Select pharmacologic interventions to manage dyslipidemia related to insulin resistance.
- Discuss non-pharmacologic strategies to help patients attain tight control of diabetes.
- Describe pharmacologic strategies to help patients attain tight control of diabetes.
- Discuss individualized lifestyle programs that enable patients at risk for diabetes to manage weight issues.
| Faculty: | ||
| Steering Committee: | Fiona Shannon, MHS, FNP | |
| Phyllis Zimmer, MN, FNP, FAAN | ||
| Jerry Price | ||
| Expert Panel: | Terry Ridge, MSN, APRN-BC, BC-ADM | |
| Mitchell King, MD | ||
| G. Allen Crist, DO, FAAFP, CAQG | ||
| Mark Molitch, MD | ||
| Reviewers: | Davida Kruger, MSN, APRN-BC, BC-ADM | |
| Francie Likis, DrPH, NP, CNM | ||
| Jane Murage, MS, NP |
Disclosure Policy: In accordance with the ANCC, NPHF requires that any person who is in a position to control the content of a CNE activity must disclose all financial relationships they have with a commercial interest (an entity that produces an FDA-regulated product).
Steering Committee Disclosures: None
Author/Guest Authors Disclosures: Ridge-Amylin Pharmaceuticals; King-none; Crist-none;
Molitch- Research; sanofi-aventis, Amgen, Speaker: sanofi-aventis, Merck, Abbott,
Consultant: sanofi-aventis, Abbott
Reviewer Disclosures:
Kruger-Research: NIH, Abbott, Amylin, Aventis, Consultant: Novo Nordisk, Abbott, Aventis,
Takeda, Council for the Advancement of Diabetes Research & Education, Diabetes Hormone
Education Coalition, Dex Com, Home Diagnostics, Inc, Patton Medical Devices, Agametrics, Shareholder: Amylin, Dex Com,
Patton Medical Devices
Likis-none; Murage-none
Non-faculty Disclosures: The Nurse Practitioner Healthcare Foundation staff involved in the development of this activity have no financial relationships with the commercial supporter of this activity or any other commercial interest(s).
Resolution of Conflicts of Interest: To resolve identified conflicts of interest of the faculty and others who were in a position to influence content, the educational content was fully peer-reviewed by a member of the NPHF who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
Method of Participation: This activity should take approximately 1.5 hours to complete. The participant may either read the article printed in the American Journal for Nurse Practitioners Vol (to be determined) or go on line to www.nphealthcarefoundation.org to view the article and register for continuing nursing education credit.
Questions re program, evaluation/registration contact: Fiona@nphealthcarefoundation.org
Disclaimer: The content and views presented in this educational activity are those of the faculty and do not necessarily reflect those of the NPHF, Illinois Critical Access Hospital Network, University of Illinois Rockford, or the Michigan Academy of Family Physicians. This material has been prepared based on a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter and should not rely solely on the information contained in this educational activity.
Note: This educational activity may contain discussion of published and/or investigational uses of agents that are not yet approved by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should consider the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
This educational activity may discuss complementary/alternative/therapeutic modalities. This discussion does not constitute endorsement of the use of any specific modality in the care of clients.
Copyright© 2008 Nurse Practitioner Healthcare Foundation
2647 134th Ave NE, Bellevue, WA 98005. 425-861-0911
